VS

Viral Shah

Active Director Managing Director DIN 01079170
DIN 01079170 First appointment Jan 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies 7 historical roles
Total affiliations 14 Since Jan 2007
Shareholding value •••• Premium profile

About Viral Shah

Data last updated:

Viral Shah is a Managing Director at Acme Formulation Private Limited (since 2007), Director at Acme Generics Private Limited (since 2021) and Managing Director at Immacule Lifesciences Private Limited (since 2010), and holds 4 more current directorships. The companies operate in Pharma, Chemicals and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹987 Cr; the largest is Acme Formulation Private Limited at ₹577 Cr (FY 2025). Earlier, Viral Shah was a Director at Msl Holdings Private Limited (2013–2014) and Director at Csk Market Services Private Limited (2009–2015) and 5 more.

DIN 01079170
Primary Designation Managing Director
Industry Pharma
First Appointment 24 Jan 2007
Oldest Company Age 22 yrs
Largest company Acme Formulation Private Limited · ₹577 Cr (FY 2025)
Combined revenue ₹987 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acme Formulation Private Limited U24230HP2004PTC027223
Managing Director24 Jan 20072004₹577 Cr (FY 2025)Active
Acme Generics Private Limited U24100PB2021PTC056566
Director30 Jul 20212021₹264 Cr (FY 2024)Active
Managing Director20 Sep 20102010₹143 Cr (FY 2025)Active
Ace Invest Private Limited U74900CH2013PTC034318
Director02 May 20192013₹2.03 Cr (FY 2025)Active
Director10 Feb 20102009₹1.03 Cr (FY 2025)Active
Designated Partner30 Oct 20142014Active
Tekno Touch Private Limited U74140GJ2009PTC057011
Director21 May 20092009Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Msl Holdings Private Limited U74999CH2007PTC030868
Director09 Feb 20132007₹232 Cr (FY 2025)Active
Csk Market Services Private Limited U74110CH2005PTC028560
Director01 May 20092005₹4.84 Cr (FY 2025)Active
Globe Ce Private Limited U29199CH2005PTC028649
Director08 Nov 20122005₹4,130 (FY 2025)Active
Globe Cv Private Limited U50300HR2012PTC065232
Director01 May 20122012₹232 Cr (FY 2025)Active
Ace Lifescience Private Limited U24239GJ2009PTC057025
Director21 May 20092009Strike Off
Designated Partner01 Apr 20212015₹264 Cr (FY 2021)Converted To Cmp And Dissolved
Designated Partner28 Jan 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Acme Generics Private Limited
Acme Formulation Private Limited
Ace Lifescience Private Limited
Tekno Touch Private Limited
Premium access

Shareholding and investment profile for Viral Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Viral Shah

Viral Shah currently holds 7 directorships: Acme Formulation Private Limited (Managing Director, since 24 Jan 2007, revenue ₹577 Cr (FY 2025)); Acme Generics Private Limited (Director, since 30 Jul 2021, revenue ₹264 Cr (FY 2024)); Immacule Lifesciences Private Limited (Managing Director, since 20 Sep 2010, revenue ₹143 Cr (FY 2025)); Ace Invest Private Limited (Director, since 02 May 2019, revenue ₹2.03 Cr (FY 2025)); Ace Testing Solutions Private Limited (Director, since 10 Feb 2010, revenue ₹1.03 Cr (FY 2025)); and 2 more.

Viral Shah was first appointed on 24 Jan 2007 as Managing Director at Acme Formulation Private Limited. The most recent appointment on record is 30 Jul 2021 at Acme Generics Private Limited.

The 5 current companies of Viral Shah that report revenue have a combined latest revenue of ₹987 Cr: Acme Formulation Private Limited ₹577 Cr (FY 2025); Acme Generics Private Limited ₹264 Cr (FY 2024); Immacule Lifesciences Private Limited ₹143 Cr (FY 2025); Ace Invest Private Limited ₹2.03 Cr (FY 2025); Ace Testing Solutions Private Limited ₹1.03 Cr (FY 2025).

Viral Shah held 7 earlier board appointments: Msl Holdings Private Limited (Director, 09 Feb 2013 to 22 Nov 2014); Csk Market Services Private Limited (Director, 01 May 2009 to 07 Dec 2015); Globe Ce Private Limited (Director, 08 Nov 2012 to 22 Nov 2014); Globe Cv Private Limited (Director, 01 May 2012 to 22 Nov 2014); Ace Lifescience Private Limited (Director, from 21 May 2009); and 2 more.

The current boards of Viral Shah's companies include Aswin Vikram (Acme Formulation Private Limited), Ginny Uppal (Acme Formulation Private Limited), Nikhil Kumar Srivastava (Acme Formulation Private Limited), Vikas Sharma (Acme Formulation Private Limited), Ruby Shah (Ambriel Life Sciences Llp), Dilipkumar Shah Bhogilal (Tekno Touch Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available